Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...
Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...
An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.
56% Increase in C. diff Due in Part to Improved Detection Hospitals that switched Clostridium difficile testing from nonmolecular to molecular methods recorded a 56 percent increase in recorded C.
Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.
A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...
A new study published today in the American Journal of Infection Control (AJIC) suggests that allowing bedside nurses to independently order testing for C. difficile significantly decreased the amount ...
The revisions address the excessive use of antibiotics in hospitals, and recommend diagnostic treatments—including fecal transplantation—to improve the care of patients with Clostridium difficile.
Talker on MSN
New antibiotic beats deadly superbug in trials
The post New antibiotic beats deadly superbug in trials appeared first on Talker. A new antibiotic to fight the deadly " superbug " C. diff has proved effective in clinical trials. Treating patients ...
After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior. Through a series of interventions ...
Tests for the Clostridium difficile infection are missing up to 20% of cases and falsely diagnosing thousands of others, researchers have said. A study by St George's, University of London, and St ...
Testing for Clostridium difficile infection is significantly lower than expected during diagnosis of inflammatory bowel disease, according to a study in Inflammatory Bowel Diseases, the official ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results